











Response to Abra `moff et al.
W
ereadwithinteresttherecentar-
ticle by Abra `moff et al.(1) but
were disappointed in their con-
clusion that automated grading software
could not be recommended for clinical
practice.
Our group’s published work (2)
shows that automated grading of diabetic
retinopathy, based on image-quality as-
sessment and microaneurysm detection,
cansafelyreducetheburdenofgradingin
diabetic retinopathy screening programs.
Comparing manual and automated grad-
ingagainstareferencestandardgradingof
14,406 images (from 6,722 patients), we
foundthatourautomatedsystemattained
a higher sensitivity for detection of pa-
tientsrequiring“fulldisease”gradingthan
the manual graders. The automated sys-
temdetected97.9%ofpatientshavingre-
ferablediabeticretinopathy.Althoughthe
speciﬁcity of the automated system was
lower than for manual graders, the grad-
ing workload was reduced and offered
useful ﬁnancial savings (3).
Screening is a means for reducing the
riskofdiseaseinthescreenedpopulation,
and, in practice, large-scale implementa-
tionmeansthatthereisacompromisebe-
tween sensitivity and speciﬁcity. Hence a
recommendation against using auto-
mated grading is only valid if it is shown
that there is a higher performing and
readily available alternate methodology.
More speciﬁcally, it is important that an
automated grading system is compared
with what can be achieved by human ex-
perts who are routinely employed within
a screening program. In the real world,
such manual grading is imperfect. For ex-
ample, we found that the full disease
graders,whosejobistobehighlyspeciﬁc,
missed 18 of 330 cases of referable dia-
betic retinopathy (2).
Hence, our main criticism of the
study by Abra `moff et al. is that the lack of
a common reference standard resulted in
insufﬁcient evidence to draw their main
conclusion, namely, that the automated
grading software could not be recom-
mended for clinical practice.
We also note two other factors that
mayhaveinﬂuencedtheresultsandmade
them difﬁcult to generalize. First, selec-
tion bias may have been a factor. The data
were selected on the basis that patients
previously shown to have diabetic reti-
nopathy are not rescreened. While this
may be the policy of the EyeCheck pro-
gram, the data may not be regarded as
“unselected” outside the context of this
particular program. Second, the authors
notethatthereseemedtobeaslighteffect
associated with increasing camera resolu-
tion. However, the results show a varia-
tion in speciﬁcity from 22 to 83%
depending on camera resolution. This
suggests that performance may be greatly
improved by using the higher resolution
images.
We congratulate Abra `moff et al. on
this study. However, we believe that the
conclusions are not universally applica-
ble. Our work shows that the automated
analysis of retinal images does have an
important role to play in diabetic retinal
screening programs.
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